RHYTHM PHARMACEUTICALS, INC.

RYTM · Nasdaq · SIC 2834: Pharmaceutical Preparations
160
SEC Filings

Business Summary

PART I Overview We are a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases. We are focused on advancing melanocortin-4 receptor (MC4R) agonists, including our lead asset, IMCIVREE (setmelanotide), as precision medicines designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. While obesity affects hundreds of millions of people worldwide, we are developing therapies for a subse...

Next Earnings

Q2 FY2026 — expected 2026-08-07

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionRYTMdiscussed_in_filing Cybersecurity
topic_mentionRYTMdiscussed_in_filing Trusted Computing
topic_mentionRYTMdiscussed_in_filing Blockchain & Crypto
topic_mentionRYTMdiscussed_in_filing Regulation
topic_mentionRYTMdiscussed_in_filing Healthcare & Bio
topic_mentionRYTMdiscussed_in_filing Sovereign & Government
topic_mentionRYTMdiscussed_in_filing Cybersecurity
topic_mentionRYTMdiscussed_in_filing Trusted Computing
topic_mentionRYTMdiscussed_in_filing Blockchain & Crypto
topic_mentionRYTMdiscussed_in_filing Regulation
topic_mentionRYTMdiscussed_in_filing Healthcare & Bio
topic_mentionRYTMdiscussed_in_filing Sovereign & Government
topic_mentionRYTMdiscussed_in_filing Cybersecurity
topic_mentionRYTMdiscussed_in_filing Trusted Computing
topic_mentionRYTMdiscussed_in_filing Blockchain & Crypto
topic_mentionRYTMdiscussed_in_filing Regulation
topic_mentionRYTMdiscussed_in_filing Healthcare & Bio
topic_mentionRYTMdiscussed_in_filing Sovereign & Government
topic_mentionRYTMdiscussed_in_filing Cybersecurity
topic_mentionRYTMdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001628280-26-012399EDGAR118K words
2025-02-282024-12-310001558370-25-001889EDGAR—
2024-02-292023-12-310001558370-24-002181EDGAR—
2023-03-012022-12-310001558370-23-002613EDGAR—
2022-03-012021-12-310001558370-22-002543EDGAR—
2021-03-012020-12-310001558370-21-002121EDGAR—
2020-03-022019-12-310001558370-20-001896EDGAR—
2019-03-082018-12-310001558370-19-001698EDGAR—
2018-03-122017-12-310001558370-18-001923EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001104659-25-106264EDGAR74K words
2025-08-052025-06-300001558370-25-010302EDGAR—
2025-05-072025-03-310001558370-25-006765EDGAR—
2024-11-062024-09-300001558370-24-014532EDGAR—
2024-08-062024-06-300001558370-24-011101EDGAR—
2024-05-072024-03-310001558370-24-007076EDGAR—
2023-11-082023-09-300001558370-23-018291EDGAR—
2023-08-012023-06-300001558370-23-012739EDGAR—
2023-05-022023-03-310001558370-23-007675EDGAR—
2022-11-082022-09-300001558370-22-016818EDGAR—
2022-08-032022-06-300001558370-22-011888EDGAR—
2022-05-032022-03-310001558370-22-006790EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-030001628280-26-023606EDGAR1K words
2026-03-260001628280-26-021414EDGAR—
2026-03-200001628280-26-019995EDGAR—
2026-03-160001628280-26-018211EDGAR—
2026-03-020001104659-26-021801EDGAR—
2026-02-260001628280-26-011987EDGAR—
2026-01-090001628280-26-001459EDGAR—
2025-12-190001104659-25-123108EDGAR—
2025-12-110001104659-25-120141EDGAR—
2025-11-070001104659-25-108154EDGAR—

160 total filings indexed. 129 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001649904
TickerRYTM
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 390a0f59ab009d665d272ca63bf61c9cc933ad1254c837fe0dd56e6c7bd4fbbc
parent: 8dc5f901942d48f0598ceeab7367c308edcb5fa11b3c78206d8c9a15f8939808
content hash: 60bc8526dd90c7676597f7cd24ad0553f33732a9b31cd973ccda660dff639cfe
signed: 2026-04-13T04:47:17.950Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf